These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33563631)

  • 1. Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
    Vitale G; Ditaranto R; Graziani F; Tanini I; Camporeale A; Lillo R; Rubino M; Panaioli E; Di Nicola F; Ferrara V; Zanoni R; Caponetti AG; Pasquale F; Graziosi M; Berardini A; Ziacchi M; Biffi M; Santostefano M; Liguori R; Taglieri N; Nardi E; Linhart A; Olivotto I; Rapezzi C; Biagini E
    Heart; 2022 Jan; 108(1):54-60. PubMed ID: 33563631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.
    Antezana-Chavez E; Cianciulli TF; Hadid CL; Toro DD; Celano L; Saccheri MC; Baez KG; Lopez CA; Labadet CD; Gagliardi JA
    Am J Cardiol; 2022 Sep; 178():131-136. PubMed ID: 35810008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
    Junqua N; Legallois D; Segard S; Lairez O; Réant P; Goizet C; Maillard H; Charron P; Milliez P; Labombarda F
    Arch Cardiovasc Dis; 2020; 113(8-9):542-550. PubMed ID: 32771348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking.
    Parisi V; Baldassarre R; Ferrara V; Ditaranto R; Barlocco F; Lillo R; Re F; Marchi G; Chiti C; Di Nicola F; Catalano C; Barile L; Schiavo MA; Ponziani A; Saturi G; Caponetti AG; Berardini A; Graziosi M; Pasquale F; Salamon I; Ferracin M; Nardi E; Capelli I; Girelli D; Gimeno Blanes JR; Biffi M; Galiè N; Olivotto I; Graziani F; Biagini E
    Front Cardiovasc Med; 2023; 10():1184361. PubMed ID: 37416917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.
    Karur GR; Robison S; Iwanochko RM; Morel CF; Crean AM; Thavendiranathan P; Nguyen ET; Mathur S; Wasim S; Hanneman K
    Radiology; 2018 Aug; 288(2):398-406. PubMed ID: 29688154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.
    Delcrè SD; Di Donna P; Leuzzi S; Miceli S; Bisi M; Scaglione M; Caponi D; Conte MR; Cecchi F; Olivotto I; Gaita F
    Int J Cardiol; 2013 Aug; 167(3):1038-45. PubMed ID: 22464482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.
    Ávila-Sánchez DA; Cambronero-Cortinas E; Barreiro-Pérez M; Rodríguez-Hernández JL; Díaz-Fernández B; Sánchez PL
    Am J Case Rep; 2020 Oct; 21():e925631. PubMed ID: 33119553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
    Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
    Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic voltage criteria in patients with hypertrophic cardiomyopathy.
    Monzo L; Martino A; Lanzillo C; Bencivenga S; Acitelli A; Fedele E; Salustri E; Bona RD; Maresca L; Silvetti E; Canestrelli S; Minati M; Penco M; Calò L
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):696-703. PubMed ID: 32639329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ECG criteria for differential diagnosis of wide QRS complex tachycardias with right bundle branch block pattern.
    Shlevkov NB; Salami HF; Kiktev VG; Sokolov SF
    Ter Arkh; 2019 May; 91(4):83-89. PubMed ID: 31094481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
    Serra W; Marziliano N
    Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anderson-Fabry disease management: role of the cardiologist.
    Pieroni M; Namdar M; Olivotto I; Desnick RJ
    Eur Heart J; 2024 Apr; 45(16):1395-1409. PubMed ID: 38486361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy.
    Akhan O; Kış M; Güzel T; Zoghi M
    Arq Bras Cardiol; 2024 Jan; 121(1):e20230229. PubMed ID: 38324858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial abnormality by electrocardiogram predicts left ventricular hypertrophy by echocardiography in the presence of right bundle-branch block.
    Mehta A; Jain AC; Morise AP; Mehta MC; Billie M
    Clin Cardiol; 1998 Feb; 21(2):109-14. PubMed ID: 9491950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome.
    Tao Y; Xu J; Bako SY; Yao X; Yang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):306. PubMed ID: 32576233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy.
    Kounas S; Demetrescu C; Pantazis AA; Keren A; Lee PJ; Hughes D; Mehta A; Elliott PM
    J Am Coll Cardiol; 2008 May; 51(21):2058-61. PubMed ID: 18498962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between left ventricular mass and QRS duration in diverse types of left ventricular hypertrophy.
    Domain G; Chouquet C; Réant P; Bongard V; Vedis T; Rollin A; Mandel F; Delasnerie H; Voglimacci-Stephanopoli Q; Mondoly P; Beneyto M; Cariou E; Fournier P; Delmas C; Galinier M; Carrié D; Lafitte S; Lairez O; Ferrières J; Cochet H; Maury P
    Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):560-568. PubMed ID: 33842939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
    Sado DM; White SK; Piechnik SK; Banypersad SM; Treibel T; Captur G; Fontana M; Maestrini V; Flett AS; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Neubauer S; Elliott PM; Moon JC
    Circ Cardiovasc Imaging; 2013 May; 6(3):392-8. PubMed ID: 23564562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.